IMPORTANCE At present, the choice of noninvasive testing for a diagnosis of significant coronary artery disease (CAD) is ambiguous, but nuclear myocardial perfusion imaging with single-photon emission tomography (SPECT) or positron emission tomography (PET) and coronary computed tomography angiography (CCTA) is predominantly used for this purpose. However, to date, prospective head-to-head studies are lacking regarding the diagnostic accuracy of these imaging modalities. Furthermore, the combination of anatomical and functional assessments configuring a hybrid approach may yield improved accuracy.
A n array of noninvasive tests is available for the diagnosis of coronary artery disease (CAD), including coronary computed tomography angiography (CCTA), single-photon emission computed tomography (SPECT), and positron emission tomography (PET). Coronary computed tomography angiography allows for the assessment of the severity of coronary stenosis, SPECT for the assessment of myocardial perfusion, and PET for absolute myocardial blood flow. 1 Furthermore, hybrid techniques that allow for the fusion of SPECT and CCTA or PET and CCTA imaging have been recently reported. [2] [3] [4] For measures of hemodynamically significant CAD, prior prospective multicenter randomized clinical trials have established invasive fractional flow reserve (FFR) to be a prognostic criterion standard, guiding decisions of revascularization resulting in improved event-free survival vs that seen with stenosis-guided revascularization. [5] [6] [7] To our knowledge, a systematic comparison of the diagnostic performances of SPECT, PET, CCTA, and hybrid imaging using invasive FFR as a reference standard has not been performed. We thus performed a prospective study to test the performances of noninvasive imaging modalities wherein CCTA, SPECT, PET, and hybrid imaging were performed for all individuals and compared against an FFR reference standard
Methods

Study Design
The Prospective Comparison of Cardiac PET/CT, SPECT/CT Perfusion Imaging and CT Coronary Angiography With Invasive Coronary Angiography (PACIFIC) study is a prospective controlled clinical single-center study conducted from January 23, 2012, to October 25, 2014, at the VU University Medical Center, Amsterdam, the Netherlands (NCT01521468). The study protocol was approved by the Medical Ethics Committee of the VU University Medical Center and all participants provided written informed consent.
Study Population
The study population comprised 208 consecutively selected patients with stable new-onset chest pain and suspected CAD (see eFigure 1 and eTable 1 in the Supplement for detailed inclusion and exclusion criteria). Patients underwent CCTA, PET, and SPECT, followed by invasive coronary angiography (ICA) and FFR measurements of all coronary arteries within 2 weeks. No cardiac events were documented in the period between the scans and catheterization. A schematic overview of the imaging protocol is shown in Figure 1 . Medication was not discontinued and was kept constant during the execution of the study protocol. A detailed description of the scan protocols is provided in the eAppendix in the Supplement.
Image Analysis and Data Interpretation
Raw image data from all scans were transferred to core laboratories. Interpretations by core laboratories were performed in a blinded fashion for CCTA (St Paul's Hospital, Vancouver, British Columbia, Canada, and the Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital, New York), SPECT (Royal Brompton Hospital, London, England), and PET (Turku University Hospital, Turku, Finland) to ensure an unbiased grading of the scans.
Cardiac Computed Tomography
The 4 main vessels (right coronary artery, left main artery, left anterior descending artery, and circumflex artery) were assessed by use of CCTA. The primary threshold was defined as a visually estimated diameter of stenosis of 50% or more. Grading of the CCTA scans was on an intention-to-diagnose basis, with noninterpretable segments considered positive for obstructive CAD.
Single-Photon Emission Computed Tomography
For SPECT myocardial perfusion imaging (MPI), perfusion in each of 17 segments was classified as normal, mild reduction, moderate reduction, severe reduction, or absent perfusion, and the segmental scores were summed for the stress and resting images. 8 Ischemia was defined by an inducible perfusion abnormality with a summed segmental difference score between stress and resting images of 2 or more. Scans were additionally quantitatively reported with the use of the total perfusion defect to assess the ischemic burden. The percentage of the myocardium that is ischemic was calculated by subtracting the resting total perfusion defect from the stress total perfusion defect.
[
O]H 2 O Positron Emission Tomography
On PET scans, myocardial segments with a hyperemic myocardial blood flow of 2.30 mL/min/g or less were considered to be abnormal. This cutoff value was predefined in a comparable population and published previously. 9 Ischemia was defined by a perfusion defect of at least 2 adjacent myocardial segments with hyperemic flow of 2.30 mL/min/g or less.
Key Points
Question What are the diagnostic performances of coronary computed tomography angiography, single-photon emission tomography, [ 15 O]H 2 O positron emission tomography, and hybrid imaging for the diagnosis of myocardial ischemia using fractional flow reserve as a reference standard?
Findings In this head-to-head comparative study of 208 adults, sensitivity was 90% for coronary computed tomography angiography, 57% for single-photon emission tomography, and 87% for positron emission tomography, whereas specificity was 60% for coronary computed tomography angiography, 94% for single-photon emission tomography, and 84% for positron emission tomography. Positron emission tomography exhibited the highest diagnostic accuracy compared with single-photon emission tomography and coronary computed tomography angiography.
Meaning Coronary computed tomography angiography and [ 
Cardiac Hybrid Imaging
To allow for a hybrid interpretation, fusion images of CCTA with SPECT or PET were generated to allocate coronary arteries to their subtended vascular territories. Hybrid images were interpreted as follows. A vessel was considered abnormal when a matched SPECT/CCTA hybrid image or PET/CCTA hybrid image occurred, which was defined as ischemia (vide supra) on a SPECT or PET MPI vascular territory subtended by a coronary artery containing 50% or more stenosis. Lesion-specific ischemia was considered absent for all the other combinations of SPECT/CCTA or PET/CCTA findings.
Statistical Analysis
The end points of this study concerned the comparison of imaging modalities in terms of sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy in identifying patients with hemodynamically significant CAD, which was defined as stenosis in at least 1 coronary artery, as indicated by an FFR of 0.80 or less or a stenosis diameter of 90% or more if FFR was lacking. The total planned study sample size was fixed at 211 patients for whom paired PET and SPECT assessments were to be obtained (eAppendix in the Supplement). The McNemar test was used to test for differences between pairs of imaging modalities in terms of sensitivity, specificity, and diagnostic accuracy at the level of the individual patient. The PPV and NPV at the level of the individual patient were compared using the marginal regression approach as proposed by Leisenring et al. 10 Secondary analyses concerned vessel-specific analyses (eAppendix in the Supplement). Furthermore, receiver operating characteristic curves were generated to determine the incremental value of noninvasive imaging above traditional risk factors. Finally, a comparison of the differences in radiation dose between different imaging modalities was performed using 1-way analysis of variance with a Bonferroni correction for multiple pairwise comparisons for localizing the source of the difference.
P < .05 was considered statistically significant. All statistical analyses were performed by using IBM SPSS Statistics, version 20 (IBM Corp), except for the mixed effects logistic regression analyses, which were performed in STATA, version 14 (StataCorp LP).
Results
All 208 included patients underwent CCTA imaging, while 2 patients had incomplete or failed SPECT procedures owing to technical problems, and 4 patients failed to complete the cardiac PET protocol mainly because of claustrophobia or technical reasons. The baseline characteristics of the patients are listed in Table 1 , and imaging examples are given in eFigure 2 in the Supplement. Table 2 and shown in Figure 2 . When analyzed on a per-patient level, the sensitivity of CCTA using the threshold of 50% diameter or greater stenosis was 90%, and the specificity was 60%. Coronary computed tomography angiography and PET exhibited a similar sensitivity (CCTA, 90%; and PET, 87%; P = .65) and NPV (CCTA, 89%; and PET, 89%; P = .95), while SPECT showed a significantly lower sensitivity (57%) and NPV (73%) when compared with CCTA (sensitivity, 90%; P < .001; and NPV, 89%; P = .002) and PET (sensitivity, 87%; and NPV, 89%, P < .001).
ICA and FFR
Compared with CCTA, specificity and PPV were significantly in favor of SPECT (specificity, 94%; P < .001; and PPV, 88%; P = .01) and PET protocols (specificity, 84%; and PPV, 81%; P < .001). Overall, CCTA and SPECT showed similar accuracy (CCTA, 74%; and SPECT, 77%; P = .51). Positron emission tomography showed a significantly higher diagnostic accuracy (85%) when compared with CCTA (74%; P = .003) and SPECT (77%; P = .02). Similar trends have been observed on a pervessel basis (eAppendix in the Supplement). The assessment of functional extent of CAD as identified by 1-, 2-, or 3-vessel disease according to an FFR of 0.80 or less has been shown in eTable 3 in the Supplement. The diagnostic performances of CCTA, SPECT, and PET when compared against anatomical reference standards (ie, ICA≥50% and ICA≥70%) and an FFR of 0.75 or less are shown in Figure 2 . In addition, the association between noninvasive cardiac imaging findings and diameter stenosis as assessed by quantitative coronary angiography is shown in eFigure 4 in the Supplement. Coronary computed tomography angiography seems to overestimate the degree of stenosis, showing a high rate of positive findings for patients with nonobstructive CAD (ie, stenosis <50%), whereas the lowest percentage of abnormal scans is seen for SPECT even for patients with greater than 90% diameter stenosis (only 81% positive SPECT scans; eFigure 4 in the Supplement). Notably, receiver operating characteristic curve analyses showed PET to possess the highest area under the curve (0.90; 95% CI, 0.85-0.94; P < .001); however, there was no statistically significant difference in the area under the curve compared with CCTA and SPECT ( Figure 3 ). Logistic regression analyses revealed that CCTA, SPECT, and PET imaging has an incremental diagnostic value beyond traditional risk factors in assessing hemodynamic significant CAD, as indicated by FFR (eTable 4 in the Supplement).
Noninferiority of SPECT Compared With PET for Diagnosis of Ischemia-Causing CAD
With regard to the primary end point, SPECT was shown to be noninferior in terms of its specificity (94%; P < .001) but not in terms of its sensitivity (57%; P > .99) using the predefined noninferiority margin of 10%. The absolute difference in specificity between SPECT and PET was 9.6% (95% CI, 1.6%-17.7%) in favor of SPECT, whereas the absolute difference in sensitivity was found to be 30.4% (95% CI, 20.9%-39.9%) in favor of PET.
Diagnostic Accuracy of Hybrid Cardiac Imaging for Diagnosis of Ischemia-Causing CAD as Indicated by FFR
The diagnostic performance of hybrid imaging for detecting hemodynamically significant lesions is listed in Table 2 . The addition of either SPECT or PET to CCTA improved the specificity compared with CCTA (SPECT, 97%; and PET, 91%; P < .001) but lowered the sensitivity from 90% to 50% when SPECT was added to CCTA and decreased to 74% for hybrid PET/CCTA (P < .001). The addition of PET to CCTA improved the specificity (92%) compared with PET alone (84%; P = .004) but also lowered the sensitivity to 74% (P = .001). No differences in specificity and sensitivity were found when the addition of SPECT to CCTA was compared with SPECT only (specificity, 94%; P = .13; sensitivity, 57%; P = .03). Coronary computed tomography angiography yielded a false-negative result for 9 patients, while 46 patients were falsely identified as having nonhemodynamically significant CAD from hybrid SPECT/CCTA and 23 were falsely identified as having nonhemodynamically significant CAD from hybrid PET/CCTA. Compared with CCTA alone (89%), hybrid imaging yielded a significantly lower NPV from SPECT/CCTA (71%; P < .001) but not from PET/CCTA (82%; P = .06). On the other hand, hybrid imaging significantly improved PPV when compared with CCTA alone (SPECT/CCTA, 94%; P = .001; PET/CCTA, 88%; P < .001). Similar results were observed for per-artery analyses (Table 2 and eAppendix in the Supplement).
Radiation Dose of Noninvasive Cardiac Imaging
The mean (SD) radiation dose of CCTA was 5.31 (1.32) mSv. The mean (SD) dose (including low-dose CCTA) was 6.01 (0.70) mSv for SPECT and 3.10 mSv for PET MPI. The radiation dose for SPECT was significantly higher compared with that for CCTA and PET (both P < .001). Positron emission tomography was associated with a significantly lower radiation dose than was CCTA (P < .001). The hybrid SPECT/CCTA protocol yielded a mean (SD) effective radiation dose of 11.3 (1.48) mSv, and the PET/CCTA protocol yielded a mean (SD) effective radiation dose of 8.41 (1.32) mSv (P < .001).
Discussion
In this controlled clinical head-to-head comparative diagnostic performance study, PET demonstrated improved accuracy compared with CCTA and SPECT for the diagnosis of coronary ischemia, as measured by FFR, in symptomatic patients with suspected CAD. Furthermore, a hybrid diagnostic approach combining a functional and anatomical assessment by PET/CCTA or SPECT/CCTA yielded no incremental diagnostic value beyond stand-alone imaging. This study possesses the following unique design features: CCTA, SPECT, and PET were compared prospectively in a true head-to-head fashion; invasive FFR of all coronary arteries, irrespective of the imaging findings, was used as the reference standard; latestgeneration techniques-such as CT-based attenuation correction in SPECT perfusion imaging-were used; and all scans were analyzed by core laboratory experts (8 of us: J.L., R.R., C.N., J.K., M.M., R.S.U., J.K.M., and K.E.) blinded to other imaging and clinical data. To our knowledge, these data represent the first comprehensive examination of commonly used noninvasive techniques to evaluate myocardial perfusion or severity of coronary artery stenosis. At present, European and US guidelines do not advocate for any specific noninvasive imaging modality over another. 11, 12 Prior studies and empirical evidence have allowed for any initial noninvasive diagnostic test to be performed, depending on local availability and expertise, access to testing, costs of testing, radiation dose, ability to exercise, and the probability of obtaining a negative result. Current professional societal guidelines advocate for noninvasive imaging to be used for patients at intermediate risk of CAD, given the higher reclassification rates for these patients based on imaging findings.
11,12
We observed the prevalence of ischemia-causing CAD to be 44%, reflecting an intermediate prevalence of significant CAD that is reflective of patients judged appropriate for noninvasive imaging by current guidelines. Although there is little consensus on the preferred imaging method, guidelines endorse the use of stress imaging given the solid evidence that ischemiaguided revascularizations improve symptoms and event-free survival when compared with a coronary stenosis-guided strategy.
6,7 Paradoxically, prior studies evaluating the diagnostic performance of noninvasive imaging modalities have focused largely on an angiographic reference standard, with 50% stenosis or more at the time of invasive angiography considered as obstructive CAD. However, an array of investiga- tions has revealed the inconsistency of high-grade stenosis and ischemia-causing coronary lesions. The Fractional Flow Reserve vs Angiography for Multivessel Evaluation (FAME) trial has demonstrated FFR to be a prognostic and clinical criterion standard, given its ability to guide decisions of revascularization in a manner that results in improvement in eventfree survival over stenosis-guided revascularization. 5, 7 More important, in the FAME study, 47% of lesions were considered intermediate in stenosis severity, and approximately onethird of these lesions resulted in coronary ischemia, while twothirds did not. 13 In this regard, our study advances the understanding of the association of noninvasive testing and the use of FFR as a reference standard. To our knowledge, this is the first study in which all coronary arteries were examined by FFR, irrespective of the presence and severity of atherosclerosis, to discern the functional relevance of CAD.
In keeping with prior reports, 14 CCTA exhibited high sensitivity (90%) and NPV (89%), even when compared directly with the FFR reference standard. Despite it being an excellent tool for ruling out hemodynamically significant CAD, CCTA performed poorly for identification of coronary lesions that cause ischemia, with 60% specificity and 64% PPV. In the recently published Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease (EVINCI) trial, the specificity of CCTA was much higher (92%), 15 a disparity most likely attributable to the prevalence of CAD and the anatomical reference standard that was used. Naturally, CCTA will be closely associated with ICA and, as such, will yield high accuracy. However, CCTA is particularly hampered by the lack of functional information, resulting in overestimation of the significance of CAD when compared against FFR. The effect of different definitions of significant CAD,conceptualized as either the degree of luminal narrowing by ICA or the impairment in coronary flow reflected by FFR, on the evaluation of CCTA in diagnostic accuracy studies can be extracted from prior studies.
16,17
For measures of myocardial perfusion abnormalities, our results showed a higher diagnostic accuracy of PET vs SPECT MPI, as compared with FFR. Although, to our knowledge, there are no other prospective head-to-head comparative trials of PET vs SPECT using FFR as a reference standard, the sensitivity and specificity of PET are in keeping with 2 recently published meta-analyses of cardiac stress studies. 18, 19 The greater diagnostic accuracy of PET vs SPECT MPI has several potential explanations, but it has been suggested that its superior performance is largely owing to its higher spatial resolution that allows for better assessment of endocardial ischemia, as well as its ability to quantify perfusion in absolute terms. 20 Of 21 patients with multivessel disease or left main disease (ie, left main coronary artery), 4 (19.0%) had normal perfusion results with SPECT, while quantitative PET correctly identified ischemia. A well-known limitation of SPECT, an imaging method dependent on relative rather than absolute perfusion assessment, is the presence of a normal study in the case of "balanced" ischemia observed in 3-vessel disease or left main disease. Prior studies have suggested a high rate of false negatives in this population that is negated by PET characteristics.
21
These findings are supported by a recently published metaanalysis suggesting a low sensitivity of SPECT when it is compared with an FFR reference standard. 22 In contrast, in our study, SPECT imaging exhibited a very high specificity. This performance characteristic has not been widely observed in prior studies and may be explained by interpretation by an expert core laboratory reader or, perhaps, by the use of CT attenuation-corrected SPECT images. Prior studies are in support of the latter, although FFR-comparison SPECT studies evaluating imaging with or without attenuation artifacts have not been performed to date.
23,24
Finally, we observed no improved accuracy for combined physiological and anatomical imaging by hybrid methods. Several investigators have advocated for this method, contending that this combined approach may allow for retention of the high sensitivity of CCTA while improving its specificity. Previous studies have shown that hybrid imaging may mitigate the limitations of each separate imaging modality, strengthening diagnostic certainty. 3, 4 Nevertheless, while such hybrid imaging was performed for this study, the widespread use of CCTA coupled with SPECT or PET will result in increased radiation exposure to the patient and may mitigate its utility in a clinical setting. We observed no incremental diagnostic value of hybrid imaging compared with stand-alone testing. Although the addition of functional imaging to CCTA improved specificity, the increase in false-negative findings affects clinical decision making in an unfavorable manner. It is expected that the addition of CT perfusion or FFR CT to CCTA for patients with an intermediate pretest likelihood of CAD will likely increase specificity at the cost of sensitivity. However, future studies are needed to determine whether hybrid CT imaging for patients at the lower spectrum of pretest probability of CAD, relying primarily on the high sensitivity and NPV of noninvasive testing, will improve accuracy and clinical decision making. However, others have argued for CT as an initial diagnostic test, maintaining the importance of ruling out CAD by CT and assessing the presence of functionally irrelevant coronary atherosclerosis, which may harbor important prognostic information, as the foremost information to be garnered from the study. In this regard, the landmark Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial revealed that the addition of information related to angiographic severity of stenosis and atherosclerosis may not be superior to stress testing for improving outcomes.
25
In addition, the recently published Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography for Diagnosis of Coronary Heart Disease (CE-MARC 2) trial 26 showed that the type of functional testing (ie, SPECT vs cardiac magnetic resonance) yields comparable outcome results.
Limitations
This study has some limitations. It was powered for noninferiority testing of SPECT compared with PET, whereas secondary end points of hybrid imaging should be interpreted with caution given the limited sample size. The prevalence of disease in this study was generally higher than reported in other trials of the diagnostic accuracy of noninvasive imaging to detect CAD; these results should be interpreted in the context of this particular patient population. The present findings can be extrapolated to patients at low risk of CAD in whom specificity of a test is less important. It is expected that with increasing prevalence, the NPV of imaging will increase at the cost of specificity and PPV. Patients with a low ischemic burden at nuclear imaging (ie, <10% of myocardium) could very well initially be treated conservatively with optimal medical therapy to control symptoms. 
Conclusions
This controlled clinical head-to-head comparative study revealed PET to exhibit the highest accuracy for diagnosis of myocardial ischemia. Furthermore, a combined anatomical and functional assessment does not add incremental diagnostic value and guides clinical decision making in an unsalutary fashion. intravenously during the scan to achieve a heart rate < 65 bpm. Each patient received 800 mcg of sublingual nitroglycerine immediately before CCTA. 
Invasive Coronary Angiography and Fractional Flow Reserve
ICA imaging was performed in at least two orthogonal directions per evaluated coronary artery segment. Prior to contrast injection, 0.2 mL of nitroglycerin was administered intracoronary to induce epicardial coronary vasodilation. The coronary tree was divided into a 16-segment coronary artery model modified from the American Heart Association. All major coronary arteries were routinely interrogated by FFR except for occluded or subtotal lesions ≥ 90%. The operator refrained from FFR measurements in these tight lesions due to the potential risk of inflicting a coronary dissection by the pressure wire. The FFR was measured using a 0.014-inch sensor tipped guide wire (Volcano Corporation, Rancho Cordova, CA, USA), which was introduced through a 5-or 6-F guiding catheter, calibrated and advanced into the coronary artery. at least one major coronary artery. In case of a missing FFR value, the endpoint was deemed positive in the presence of subtotal lesion ≥ 90%, and negative when diameter stenosis was  30% (obtained with QCA). All images and FFR signals were interpreted by two experienced interventional cardiologists (N.v.R. and P.K.) blinded to the noninvasive cardiac imaging results.
Outcome and safety
Follow-up data were collected at one year after the ICA from contact with the patients' physicians, medical record and telephone interviews using a standardized questionnaire.
Outcome end points included a composite of major adverse cardiovascular events (MACEs: cardiovascular death, myocardial infarction, unplanned coronary revascularization and hospital admission for cardiovascular cause) within 12 months. Revascularization procedures related as a clinical consequence of the initial ICA were not considered as MACE. Complications directly related to study investigations resulting in prolonged hospital stay or specific treatment were prespecified as safety end points.
Power analysis
Assuming a sensitivity of PET of 90% and a non-inferiority margin of 10% a total number of 105 patients with hemodynamic significant stenosis yield 80% power to show non-inferiority of SPECT in case of the sensitivity of SPECT also being 90%. Power calculations are based on a one-sided non-inferiority test for correlated proportions and assuming a one-sided significance level of 5%. The total percentage of patients with discordant results is assumed to be 15% in this calculation. Similarly, 105 patients without hemodynamic significant stenosis are needed to test the same non-inferiority hypothesis for the specificity assuming specificity for PET of 90% (and a specificity of 90% for SPECT under the alternative hypothesis). Power for the test for sensitivity under these assumptions is still above 70% in case of sampling only 85 patients with hemodynamic significant CAD. The threshold of 10% was based on the meta-analysis of
McArdle et al (4) . Non-inferiority test of Tango (5) was used to separately test the primary hypotheses of non-inferiority of SPECT as compared to PET in terms of sensitivity and specificity (one sided p < 0.025 was considered significant to account for both testing sensitivity and specificity).
© 2017 American Medical Association. All rights reserved.
RESULTS
Fractional flow reserve measurements
FFR was not performed in 58 (9.4%) coronary arteries, which were either completely (n = 24) or sub-totally (n = 34) occluded. Of the subtotal occlusions, 4 were severe LM stenoses (≥ 90%) in which FFR wire passage was not attempted. These 58 sub-total lesions were deemed hemodynamically significant. In 3 (0.49%) vessels, FFR could not be performed due to severe coronary artery tortuosity that precluded the passage of the pressure wire. None of these vessels displayed a ≥ 30% stenosis and were therefore considered as being absent for hemodynamically significant CAD. Of note, NPV of SPECT was significantly lower than CCTA (p = 0.05) and PET (p < 0.01).
Compared with CCTA, PPV was significantly higher for SPECT and PET protocols (both p < 0.001). Yet, specificity was higher for SPECT when compared to CCTA (p < 0.001), but no difference in specificity was found between PET and CCTA (p = 0.74). Overall, no difference in accuracy was seen between SPECT and PET MPI on a per-vessel level (p=0.33), yet diagnostic accuracy of SPECT was higher compared to CCTA (p = 0.02) for detection of lesion-specific ischemia. There were no clear patterns that could be identified to account for the false positive or false negative findings for each of the imaging modalities (e.g. age, gender, body weight, affected coronary artery, heart rate etc. 
